Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice

Liu, Y., Reiken, S., Dridi, H., Yuan, Q., Mohammad, K. S., Trivedi, T., Miotto, M. C., Wedderburn-Pugh, K., Sittenfeld, L., Kerley, Y., Meyer, J. A., Peters, J. S., Persohn, S. C., Bedwell, A. A., Figueiredo, L. L., Suresh, S., She, Y., Soni, R. K., Territo, P. R., … Guise, T. A. (2023). Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice. Science Translational Medicine, 15(715). https://doi.org/10.1126/scitranslmed.adf8977
Authors:
Yang Liu
Steven Reiken
Haikel Dridi
Qi Yuan
Khalid S Mohammad
Trupti Trivedi
Marco C Miotto
Kaylee Wedderburn-Pugh
Leah Sittenfeld
Ynez Kerley
Jill A Meyer
Jonathan S Peters
Scott C Persohn
Amanda A Bedwell
Lucas L Figueiredo
Sukanya Suresh
Yun She
Rajesh Kumar Soni
Paul R Territo
Andrew R Marks
Theresa A Guise
Affiliated Authors:
Yang Liu
Steven Reiken
Haikel Dridi
Qi Yuan
Marco C Miotto
Kaylee Wedderburn-Pugh
Leah Sittenfeld
Ynez Kerley
Rajesh Kumar Soni
Andrew R Marks
Publication Type:
Article
Unique ID:
10.1126/scitranslmed.adf8977
PMID:
Publication Date:
Data Source:
PubMed

Record Created: